Herantis Pharma to Participate in Three Upcoming Virtual Investor Conferences
Herantis Pharma Plc Company Release 4 March 2021 at 8:00 a.m. EET Press Release Herantis Pharma Plc (“Herantis”), an innovative clinical stage biotech company pioneering new disease modifying and regenerative biologic and gene therapies, today announced that Craig Cook, Chief Executive Officer, will be participating at the upcoming virtual investor conferences, where he will be presenting and holding 1x1 meetings. Event: H.C. Wainwright Global Life Sciences Conference Format: Presentation & 1x1’s Dates: March 9 – 10, 2021 Webcasting link: https://journey.ct.events/view/